Vanda: 4Q Earnings Snapshot

WASHINGTON (AP) _ Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported fourth-quarter net income of $10.4 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Washington-based company said it had net income of 19 cents. Earnings, adjusted for non-recurring costs, came to 26 cents per share.

The biopharmaceutical company posted revenue of $53 million in the period, which beat Street forecasts. Three analysts surveyed by Zacks expected $51.3 million.

For the year, the company reported net income of $25.2 million, or 48 cents per share, swinging to a profit in the period. Revenue was reported as $193.1 million.

Vanda shares have decreased 30 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $18.42, a rise of 16 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VNDA at https://www.zacks.com/ap/VNDA